CSI Market
Sign In | Register

Green Vision Biotechnology (GVBT) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access GVBT Annual Cash Flow →
This cash flow overview for Green Vision Biotechnology spans from Jun 30 2021 to Jun 30 2022, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2022)
6 Months 		(Mar 31 2022) (Dec 31 2021) (Sep 30 2021) (Jun 30 2021)
Operating Activities
Income-1.24
Depreciation & amortization0.05
Amortization of Other Assets0.01
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Other Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.01
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Long Term Lease Prepayments-
Bad Debt Reversal-
Long Term Lease Prepayment-
Allowance For Loan And Lease Loss Recovery Of Bad Debts-
Inventory Provision-
Inventory Provision Reversal-0.01
Net Loss Income0.00
Increase Decrease In Restricted Cash Operating-
Other Tax Payables-
Income taxes-0.02
Losses/ -gains on Investments net0.00
Increase (Decrease) in Other Receivables0.00
Accounts Payable0.05
Accrued Expense0.03
Increase (Decrease) in Customer Advances0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.08
Discontinued operations0.00
Net Cash flow from Operating Activities-0.03
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Increase (Decrease) in Restricted Cash and Investments0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds Of Advance To Affiliate-
Amount Due To Shareholders-
Amounts Due To Shareholder0.01
Net Cash Provided By Used In Investing Activities Of Discontinued Operations-
Net Cash Provided By Investing Activities Of Discontinued Operations-
Net Cash Provided By Discontinued Operation-
Net Cash Provided By Used In Investing Activities Of Discontinued-
Net Increase Decrease In Cash From Discontinued Operations-
Net Cash Provided By Investing Activities Of-
Net Cash Provided By Discontinued Operations-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.01
Effect of exchange rate on cash flow0.02
Discontinued operations0.00
Free Cash Flow-0.03
Total Cash Flow-0.01
4 historic quarters locked

Sign in to unlock the full Green Vision Biotechnology cash flow history.

Sign In Create Free Account

About Green Vision Biotechnology Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001640334-22-002058

Figures are derived from filed reports and may be restated. Historical data is subject to revision.